Cargando…
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
Glioblastoma is the most common adult brain tumour, representing a high degree of malignancy. Transcription factors such as RUNX1 are believed to be involved in the malignancy of glioblastoma. RUNX1 functions as an oncogene or tumour suppressor gene with diverse target genes. Details of the effects...
Autores principales: | Hattori, Etsuko Yamamoto, Masuda, Tatsuya, Mineharu, Yohei, Mikami, Masamitsu, Terada, Yukinori, Matsui, Yasuzumi, Kubota, Hirohito, Matsuo, Hidemasa, Hirata, Masahiro, Kataoka, Tatsuki R., Nakahata, Tatsutoshi, Ikeda, Shuji, Miyamoto, Susumu, Sugiyama, Hiroshi, Arakawa, Yoshiki, Kamikubo, Yasuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463152/ https://www.ncbi.nlm.nih.gov/pubmed/36085167 http://dx.doi.org/10.1038/s42003-022-03917-5 |
Ejemplares similares
-
Author Correction: A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
por: Hattori, Etsuko Yamamoto, et al.
Publicado: (2022) -
ET-06 Suppression of glioblastoma through novel drug based on “Gene Switch Technology”
por: Yamamoto, Etsuko, et al.
Publicado: (2020) -
RUNX1–Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors
por: Mikami, Masamitsu, et al.
Publicado: (2022) -
RUNX inhibitor suppresses graft‐versus‐host disease through targeting RUNX‐NFATC2 axis
por: Kubota, Hirohito, et al.
Publicado: (2021) -
RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia
por: Masuda, Tatsuya, et al.
Publicado: (2021)